JPY7,332.00
0.20% today
Tokyo, Feb 28, 07:15 am CET
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Otsuka Stock price

JPY7,347.00
-687.00 8.55% 1M
-1,195.00 13.99% 6M
-1,253.00 14.57% YTD
+1,273.00 20.96% 1Y
+3,384.00 85.39% 3Y
+3,095.00 72.79% 5Y
+3,762.50 104.97% 10Y
Tokyo, Closing price Thu, Feb 27 2025
-31.00 0.42%
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Key metrics

Market capitalization JPY3.95t
Enterprise Value JPY3.75t
P/E (TTM) P/E ratio 11.59
EV/FCF (TTM) EV/FCF 14.49
EV/Sales (TTM) EV/Sales 1.61
P/S ratio (TTM) P/S ratio 1.69
P/B ratio (TTM) P/B ratio 1.44
Dividend yield 1.63%
Last dividend (FY25) JPY120.00
Revenue growth (TTM) Revenue growth 15.42%
Revenue (TTM) Revenue JPY2.33t
EBIT (operating result TTM) EBIT JPY396.85b
Free Cash Flow (TTM) Free Cash Flow JPY259.08b
Cash position JPY426.17b
EPS (TTM) EPS JPY633.78
P/E forward 13.92
P/S forward 1.67
EV/Sales forward 1.59
Show more

Is Otsuka a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Otsuka Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Otsuka forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Otsuka forecast:

Buy
64%
Hold
36%

Financial data from Otsuka

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,329,860 2,329,860
15% 15%
100%
- Direct Costs 660,432 660,432
8% 8%
28%
1,669,428 1,669,428
19% 19%
72%
- Selling and Administrative Expenses 850,365 850,365
20% 20%
36%
- Research and Development Expense 314,232 314,232
2% 2%
13%
504,831 504,831
29% 29%
22%
- Depreciation and Amortization 107,979 107,979
10% 10%
5%
EBIT (Operating Income) EBIT 396,852 396,852
36% 36%
17%
Net Profit 343,120 343,120
182% 182%
15%

In millions JPY.

Don't miss a Thing! We will send you all news about Otsuka directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded in1950 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Makoto Inoue
Founded 1921
Website www.otsuka.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today